In summary, we identified that LRRC15 and SPP1 could serve as inflammation‐associated candidate hub genes or potential therapeutic targets in CAVD and OA using bioinformatics and machine learning. Here, LRRC15 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.